Prescription Drugs 2 Go

Discussion  To our knowledge, this is the first attempt to investigate which of the above mentioned regimens is optimal for normo-ovulatory
women in FET cycles. A similar delivery outcome was observed for hCG–induced natural and CC-induced cycles used for endometrial
preparation in FET.
Content Type Journal ArticleDOI 10.1007/s10815-010-9464-xAuthors
Dimitra Kyrou, Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, 101 Laarbeeklaan, 1090 Brussel, BelgiumHuman M. Fatemi, Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, 101 Laarbeeklaan, 1090 Brussel, BelgiumChristophe Blockeel, Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, …

CONCLUSIONS
The chances of live birth in women with WHO Group II anovulatory infertility resistant to CC undergoing ovulation induction with gonadotrophins is highly influenced by the menstrual cycle pattern. Increases in duration of infertility and concentration of FSH (within the normal range) before the start of stimulation have negative influences on the likelihood of achieving a live birth. (Source: Human Reproduction)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

A 32-year-old woman was evaluated because of oligomenorrhea and difficulty becoming pregnant. At 25 years of age, after 5 years of oral contraceptive use, irregular menstrual cycles developed, and she was unable to become pregnant. She reported acne and increased facial hair; results of laboratory tests were consistent with anovulation. She became pregnant after two cycles of clomiphene, gestational diabetes developed, she delivered a healthy infant, and she breast-fed normally. Glucose intolerance and amenorrhea persisted after delivery. A diagnostic test was performed. (Source: New England Journal of Medicine)

MedWorm Message: Register …

Conclusion  Letrozole and LOD are equally effective for inducing ovulation and achieving pregnancy in CC-resistant PCOS patients.
Content Type Journal ArticleCategory Reproductive MedicineDOI 10.1007/s00404-010-1566-2Authors
Hatem Abu Hashim, Mansoura Faculty of Medicine, Mansoura University Departments of Obstetrics and Gynecology Mansoura EgyptAbdel Maged Mashaly, Mansoura Faculty of Medicine, Mansoura University Departments of Obstetrics and Gynecology Mansoura EgyptAhmed Badawy, Mansoura Faculty of Medicine, Mansoura University Departments of Obstetrics and Gynecology Mansoura Egypt
Journal Archives of Gynecology and ObstetricsOnline ISSN 1432-0711Print ISSN 0932-0067 (Source: Archives of Gynecology and Obstetrics)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and …

CONCLUSIONS
There is no evidence that adding metformin to ‘standard care’ is beneficial. Pregnancy and live birth rates are low in women with BMI > 32 kg/m2 whatever treatment is used, with no evidence of benefit of metformin over placebo. For women with BMI ≤ 32 kg/m2 there is no evidence of significant differences in outcomes whether treated with metformin, CC or both.
ClinicalTrials.gov number NCT00795808; trial protocol accepted for publication November 2005: Johnson, Aust N Z Journal Obstet Gynaecol 2006;46:141–145. (Source: Human Reproduction)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, …

Gynecol Obstet Invest 2010;70:166–172 (DOI:10.1159/000316265) (Source: Gynecologic and Obstetric Investigation)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Discussion  Although metformin and CC are two effective first-line approaches for improving pregnancy rates in anovulatory PCOS women,
CC is associated with higher rates of ovulation.
Content Type Journal ArticleCategory Reproductive MedicineDOI 10.1007/s00404-010-1497-yAuthors
Safak Baran, Haseki Education and Research Hospital Department of Obstetrics and Gynecology Istanbul TurkeyMurat Api, Haseki Education and Research Hospital Department of Obstetrics and Gynecology Istanbul TurkeyBehiye Pinar Cilesiz Goksedef, Haseki Education and Research Hospital Department of Obstetrics and Gynecology Istanbul TurkeyAhmet Cetin, Haseki Education and Research Hospital Department of Obstetrics and Gynecology Istanbul Turkey
Journal Archives of Gynecology and ObstetricsOn…

Abstract: Currently, few users of anabolic–androgenic steroids (AAS) seek substance abuse treatment. But this picture may soon change substantially, because illicit AAS use did not become widespread until the 1980s, and consequently the older members of this AAS-using population – those who initiated AAS as youths in the 1980s – are only now reaching middle age. Members of this group, especially those who have developed AAS dependence, may therefore be entering the age of risk for cardiac and psychoneuroendocrine complications sufficient to motivate them for substance abuse treatment. We suggest …

Abstract: Currently, few users of anabolic–androgenic steroids (AAS) seek substance abuse treatment. But this picture may soon change substantially, because illicit AAS use did not become widespread until the 1980s, and consequently the older members of this AAS-using population – those who initiated AAS as youths in the 1980s – are only now reaching middle age. Members of this group, especially those who have developed AAS dependence, may therefore be entering the age of risk for cardiac and psychoneuroendocrine complications sufficient to motivate them for substance abuse treatment. We suggest …

DEAR MAYO CLINIC: I am trying to get pregnant and my doctor suggests Clomid. Are fertility drugs harmful (physically or intellectually) to the baby?
ANSWER: No. You will not be putting your baby’s health at risk if you choose to take clomiphene (Clomid)…. (Source: OrlandoSentinel: Medical Research)